GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Cyclically Adjusted PS Ratio

Raia Drogasil (BSP:RADL3) Cyclically Adjusted PS Ratio : 1.77 (As of Apr. 27, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Raia Drogasil's current share price is R$25.62. Raia Drogasil's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was R$14.49. Raia Drogasil's Cyclically Adjusted PS Ratio for today is 1.77.

The historical rank and industry rank for Raia Drogasil's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSP:RADL3' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.54   Med: 2.14   Max: 3.18
Current: 1.76

During the past years, Raia Drogasil's highest Cyclically Adjusted PS Ratio was 3.18. The lowest was 1.54. And the median was 2.14.

BSP:RADL3's Cyclically Adjusted PS Ratio is ranked worse than
60.12% of 331 companies
in the Healthcare Providers & Services industry
Industry Median: 1.18 vs BSP:RADL3: 1.76

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Raia Drogasil's adjusted revenue per share data for the three months ended in Dec. 2023 was R$5.202. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R$14.49 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Raia Drogasil Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Raia Drogasil's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Cyclically Adjusted PS Ratio Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.86 2.76 2.20 1.82 2.03

Raia Drogasil Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 1.79 2.18 1.97 2.03

Competitive Comparison of Raia Drogasil's Cyclically Adjusted PS Ratio

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Cyclically Adjusted PS Ratio falls into.



Raia Drogasil Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Raia Drogasil's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=25.62/14.49
=1.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Raia Drogasil's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=5.202/156.2729*156.2729
=5.202

Current CPI (Dec. 2023) = 156.2729.

Raia Drogasil Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.961 90.447 1.660
201406 1.039 91.838 1.768
201409 1.116 92.602 1.883
201412 1.171 94.194 1.943
201503 0.000 97.799 0.000
201506 0.000 100.006 0.000
201509 0.000 101.392 0.000
201512 5.196 104.247 7.789
201603 1.468 106.979 2.144
201606 1.625 108.851 2.333
201609 1.694 109.986 2.407
201612 1.784 110.802 2.516
201703 3.562 111.869 4.976
201706 1.887 112.115 2.630
201709 3.983 112.777 5.519
201712 2.042 114.068 2.798
201803 2.003 114.868 2.725
201806 2.109 117.038 2.816
201809 2.193 117.881 2.907
201812 2.334 118.340 3.082
201903 2.308 120.124 3.003
201906 2.466 120.977 3.185
201909 2.685 121.292 3.459
201912 2.791 123.436 3.533
202003 2.888 124.092 3.637
202006 2.606 123.557 3.296
202009 2.961 125.095 3.699
202012 3.235 129.012 3.919
202103 3.249 131.660 3.856
202106 3.405 133.871 3.975
202109 3.581 137.913 4.058
202112 3.762 141.992 4.140
202203 3.789 146.537 4.041
202206 4.331 149.784 4.519
202209 4.526 147.800 4.785
202212 4.749 150.207 4.941
202303 4.533 153.352 4.619
202306 5.041 154.519 5.098
202309 5.138 155.464 5.165
202312 5.202 156.273 5.202

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Raia Drogasil  (BSP:RADL3) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Raia Drogasil Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (BSP:RADL3) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines